146 146 (Rivastigmine Tartrate 3 mg)
Pill with imprint 146 146 is Orange, Capsule-shape and has been identified as Rivastigmine Tartrate 3 mg. It is supplied by Sun Pharmaceutical Industries Inc..
Rivastigmine is used in the treatment of alzheimer's disease; lewy body dementia; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 146 146
Rivastigmine Tartrate
- Imprint:
- 146 146
- Strength:
- 3 mg
- Color:
- Orange
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sun Pharmaceutical Industries Inc.
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
silicon dioxide
gelatin
titanium dioxide
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
More about rivastigmine
- Rivastigmine Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 21 Reviews
- Drug class: cholinesterase inhibitors
Consumer resources
- Rivastigmine
- Rivastigmine transdermal
- Rivastigmine Capsules
- Rivastigmine Oral Solution
- Rivastigmine Patch
- ... +2 more
Other brands: Exelon
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
